secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2023-09-22T23:59:59+00:00
Accession:  0001193125-23-240624
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics receives Nasdaq delisting notices for MVLS and bid price deficiencies
--------------------------------------------------------------------------------

- Notices: MVLS below $50M and bid price below $1.00 for 30 consecutive business days.
- Compliance deadline is March 20, 2024; 180-day cure period for both requirements.
- If not compliant, faces delisting; may appeal or transfer to Nasdaq Capital Market.
- Company will monitor and consider options but cannot assure compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312523240624/0001193125-23-240624-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312523240624/d551276d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-240624

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer